Načítá se...
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS with Survival after Recurrence in Stage III Colon Cancers from Phase III Adjuvant Chemotherapy Trials
IMPORTANCE: The association of biomarkers with patient survival after recurrence (SAR) is poorly understood, yet may guide management and treatment. OBJECTIVE: To determine the association of DNA mismatch repair (MMR) status and somatic mutations in BRAF(V600E) or KRAS (exon 2) in the primary tumor...
Uloženo v:
| Vydáno v: | JAMA Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5498991/ https://ncbi.nlm.nih.gov/pubmed/28006055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.5469 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|